Novartis Looks to Buy French Firm to Bolster Cancer Portfolio

The $3.9 billion acquisition of Advanced Accelerator Applications would mark a rare deal in the pharmaceutical sector this year.

from NYT > Health http://ift.tt/2gNdsGp
via health&fitness